Login to Your Account

Financings Roundup

Acceleron Gets $30M Series F For Anemia, Cancer, DMD Trials

By Trista Morrison
Staff Writer

Wednesday, December 28, 2011

Acceleron Pharma Inc. raised $30 million in its first major venture round since 2007, tapping a syndicate of existing investors to supplement recent partnering income.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription